ORIENT BIO Inc.
KRX:002630.KS
469 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 28,819.03 | 28,819.028 | 26,276.462 | 52,020.405 | 37,699.313 | 30,373.354 | 121,207.763 | 109,019.002 | 105,049.546 | 93,709.381 | 83,722.281 | 76,980.372 | 52,052.582 | 48,171.311 | 44,736.561 | 42,803.189 | 43,857.141 | 22,451.71 |
| Cost of Revenue
| 18,994.58 | 18,994.584 | 17,262.893 | 32,792.9 | 30,499.741 | 27,362.556 | 106,283.139 | 100,648.064 | 88,964.054 | 77,161.906 | 70,482.194 | 59,229.682 | 37,430.885 | 38,073.049 | 32,987.353 | 30,401.856 | 29,608.976 | 14,624.422 |
| Gross Profit
| 9,824.45 | 9,824.444 | 9,013.569 | 19,227.505 | 7,199.572 | 3,010.797 | 14,924.624 | 8,370.938 | 16,085.492 | 16,547.475 | 13,240.088 | 17,750.69 | 14,621.697 | 10,098.262 | 11,749.208 | 12,401.333 | 14,248.165 | 7,827.288 |
| Gross Profit Ratio
| 0.341 | 0.341 | 0.343 | 0.37 | 0.191 | 0.099 | 0.123 | 0.077 | 0.153 | 0.177 | 0.158 | 0.231 | 0.281 | 0.21 | 0.263 | 0.29 | 0.325 | 0.349 |
| Reseach & Development Expenses
| 1,801.33 | 1,801.325 | 2,594.946 | 2,645.273 | 1,406.216 | 655.278 | 2,000.178 | 1,162.56 | 576.227 | 551.162 | 426.193 | 704.077 | 1,604.452 | 1,405.299 | 1,482.847 | 1,346.63 | 1,216.13 | 30.793 |
| General & Administrative Expenses
| 697.599 | 669.969 | 618.536 | 1,306.394 | 3,058.415 | 4,447.873 | 1,956.952 | 1,749.54 | 1,830.226 | 1,702.09 | 1,168.709 | 1,178.433 | 1,269.324 | 998.866 | 830.118 | 962.416 | 874.716 | 723.35 |
| Selling & Marketing Expenses
| 3,088.98 | 2,338.385 | 1,885.439 | 2,179.469 | 1,779.801 | 1,953.46 | 4,686.687 | 4,610.56 | 4,328.992 | 3,429.893 | 2,917.268 | 3,023.965 | 2,357.603 | 3,071.142 | 2,500.063 | 1,616.094 | 2,527.369 | 1,846.989 |
| SG&A
| 5,984.14 | 3,008.353 | 2,503.975 | 3,485.863 | 4,838.215 | 6,401.333 | 6,643.639 | 6,360.1 | 6,159.219 | 5,131.983 | 4,085.978 | 4,202.397 | 3,626.927 | 4,070.008 | 3,330.181 | 2,578.51 | 3,402.085 | 2,570.339 |
| Other Expenses
| -28,375.787 | -245.351 | 194.384 | 27.789 | 120.941 | 16.323 | -203.671 | -2,566.745 | 2,320.016 | -44.286 | -1,976.691 | -310.529 | 8,969.12 | 120.028 | -10,702.02 | 252.034 | -2,111.263 | -4.758 |
| Operating Expenses
| 8,371.64 | 8,371.637 | 12,794.323 | 17,368.001 | 18,448.847 | 12,243.514 | 21,487.362 | 17,658.745 | 15,974.111 | 15,643.491 | 15,038.291 | 14,255.955 | 14,200.499 | 13,089.807 | 14,112.079 | 10,239.291 | 11,613.442 | 6,671.153 |
| Operating Income
| 1,452.81 | 1,452.807 | -3,780.754 | 1,859.505 | -11,249.275 | -10,123.767 | -6,562.738 | -9,287.807 | 111.38 | 903.984 | -1,798.204 | 3,494.735 | -10,343.741 | -2,991.544 | -2,362.87 | 2,162.044 | 2,634.726 | 1,156.134 |
| Operating Income Ratio
| 0.05 | 0.05 | -0.144 | 0.036 | -0.298 | -0.333 | -0.054 | -0.085 | 0.001 | 0.01 | -0.021 | 0.045 | -0.199 | -0.062 | -0.053 | 0.051 | 0.06 | 0.051 |
| Total Other Income Expenses Net
| -14,043.54 | -14,043.539 | 419.549 | -17,618.069 | -394.746 | -3,949.216 | -9,647.983 | -13,484.119 | -2,742.294 | -2,724.35 | -8,436.278 | -2,091.416 | -9,983.335 | 5,163.199 | -10,309.749 | -2,278.357 | -4,774.76 | -629.403 |
| Income Before Tax
| -12,590.73 | -12,590.732 | -3,361.205 | -15,667.849 | -11,644.022 | -13,181.933 | -16,210.72 | -22,771.926 | -2,630.914 | -1,820.366 | -10,234.482 | 1,403.319 | -9,562.137 | 2,171.654 | -12,672.62 | -116.315 | -2,140.037 | 526.732 |
| Income Before Tax Ratio
| -0.437 | -0.437 | -0.128 | -0.301 | -0.309 | -0.434 | -0.134 | -0.209 | -0.025 | -0.019 | -0.122 | 0.018 | -0.184 | 0.045 | -0.283 | -0.003 | -0.049 | 0.023 |
| Income Tax Expense
| -167.02 | -167.024 | 69.125 | -34.442 | 1,660.51 | 5,256.143 | -3,640.968 | 2,068.926 | -115.146 | -34.275 | -16.569 | 128.267 | -762.058 | -43.206 | -16,839.274 | 323.705 | 622.078 | 672.101 |
| Net Income
| 8,410.922 | -12,423.708 | 34,198.169 | -15,633.538 | -10,880.762 | -19,505.95 | -13,865.151 | -19,126.521 | -3,009.261 | -1,749.195 | -9,550.821 | 878.817 | -10,601.939 | 4,066.486 | -579.886 | -622.871 | -4,556.272 | 526.732 |
| Net Income Ratio
| 0.292 | -0.431 | 1.301 | -0.301 | -0.289 | -0.642 | -0.114 | -0.175 | -0.029 | -0.019 | -0.114 | 0.011 | -0.204 | 0.084 | -0.013 | -0.015 | -0.104 | 0.023 |
| EPS
| 70.94 | -104.78 | -13.15 | -138.07 | -105.42 | -251.44 | -82.87 | -116.7 | -45.93 | -14.9 | -89.39 | 6.68 | -107 | 41.42 | -5.58 | -7.17 | -74.08 | 8.76 |
| EPS Diluted
| 70.94 | -104.78 | -13.15 | -138.07 | -105.42 | -251.44 | -82.87 | -116.7 | -45.43 | -14.9 | -89.39 | 6.68 | -107 | 41.42 | -5.58 | -7.17 | -74.08 | 8.76 |
| EBITDA
| -370.66 | 6,612.782 | 1,624.103 | 2,767.316 | -4,575.209 | -2,222.901 | -561.862 | -4,887.197 | 8,160.995 | 7,760.132 | 1,391.674 | 7,102.371 | -1,898.945 | 1,085.511 | -7,860.827 | 5,699.055 | 7,185.157 | 3,407.541 |
| EBITDA Ratio
| -0.013 | 0.229 | 0.062 | 0.053 | -0.121 | -0.073 | -0.005 | -0.045 | 0.078 | 0.083 | 0.017 | 0.092 | -0.036 | 0.023 | -0.176 | 0.133 | 0.164 | 0.152 |